nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—CSF1R—IgA glomerulonephritis	0.569	1	CbGaD
Nilotinib—UGT1A1—urine—IgA glomerulonephritis	0.00639	0.0648	CbGeAlD
Nilotinib—FRK—lymphoid tissue—IgA glomerulonephritis	0.00342	0.0347	CbGeAlD
Nilotinib—BLK—lymphoid tissue—IgA glomerulonephritis	0.0033	0.0334	CbGeAlD
Nilotinib—CDC42BPB—cortex of kidney—IgA glomerulonephritis	0.00327	0.0331	CbGeAlD
Nilotinib—EPHB2—lymphoid tissue—IgA glomerulonephritis	0.00326	0.0331	CbGeAlD
Nilotinib—MAPK8—kidney—IgA glomerulonephritis	0.00304	0.0308	CbGeAlD
Nilotinib—MAPK8—cortex of kidney—IgA glomerulonephritis	0.00296	0.03	CbGeAlD
Nilotinib—CYP2C9—urine—IgA glomerulonephritis	0.00269	0.0272	CbGeAlD
Nilotinib—MAPK8—lymphoid tissue—IgA glomerulonephritis	0.00261	0.0264	CbGeAlD
Nilotinib—Imatinib—CSF1R—IgA glomerulonephritis	0.00241	0.869	CrCbGaD
Nilotinib—LYN—lymphoid tissue—IgA glomerulonephritis	0.00241	0.0244	CbGeAlD
Nilotinib—MAP4K1—lymphoid tissue—IgA glomerulonephritis	0.00237	0.024	CbGeAlD
Nilotinib—CA7—kidney—IgA glomerulonephritis	0.00225	0.0228	CbGeAlD
Nilotinib—EPHB4—nephron tubule—IgA glomerulonephritis	0.00208	0.0211	CbGeAlD
Nilotinib—CYP3A4—urine—IgA glomerulonephritis	0.00205	0.0208	CbGeAlD
Nilotinib—EPHA2—nephron tubule—IgA glomerulonephritis	0.00204	0.0207	CbGeAlD
Nilotinib—CYP2D6—urine—IgA glomerulonephritis	0.00202	0.0204	CbGeAlD
Nilotinib—HCK—lymphoid tissue—IgA glomerulonephritis	0.00198	0.02	CbGeAlD
Nilotinib—MAPK14—kidney—IgA glomerulonephritis	0.00193	0.0195	CbGeAlD
Nilotinib—EPHB4—kidney—IgA glomerulonephritis	0.00183	0.0185	CbGeAlD
Nilotinib—EPHB4—cortex of kidney—IgA glomerulonephritis	0.00178	0.018	CbGeAlD
Nilotinib—TEK—kidney—IgA glomerulonephritis	0.00175	0.0177	CbGeAlD
Nilotinib—TEK—cortex of kidney—IgA glomerulonephritis	0.0017	0.0173	CbGeAlD
Nilotinib—MAPK14—lymphoid tissue—IgA glomerulonephritis	0.00166	0.0168	CbGeAlD
Nilotinib—FGR—lymphoid tissue—IgA glomerulonephritis	0.00165	0.0167	CbGeAlD
Nilotinib—EPHB6—cortex of kidney—IgA glomerulonephritis	0.00163	0.0165	CbGeAlD
Nilotinib—EPHA2—lymphoid tissue—IgA glomerulonephritis	0.00154	0.0156	CbGeAlD
Nilotinib—UGT1A1—kidney—IgA glomerulonephritis	0.00151	0.0153	CbGeAlD
Nilotinib—TEK—lymphoid tissue—IgA glomerulonephritis	0.0015	0.0152	CbGeAlD
Nilotinib—CA12—kidney—IgA glomerulonephritis	0.00146	0.0148	CbGeAlD
Nilotinib—KIT—nephron tubule—IgA glomerulonephritis	0.00144	0.0146	CbGeAlD
Nilotinib—MAP2K5—cortex of kidney—IgA glomerulonephritis	0.00139	0.0141	CbGeAlD
Nilotinib—PDGFRA—lymphoid tissue—IgA glomerulonephritis	0.00136	0.0138	CbGeAlD
Nilotinib—KIT—kidney—IgA glomerulonephritis	0.00127	0.0128	CbGeAlD
Nilotinib—ABL1—nephron tubule—IgA glomerulonephritis	0.00125	0.0127	CbGeAlD
Nilotinib—PDGFRB—kidney—IgA glomerulonephritis	0.00124	0.0125	CbGeAlD
Nilotinib—KIT—cortex of kidney—IgA glomerulonephritis	0.00123	0.0125	CbGeAlD
Nilotinib—PDGFRB—cortex of kidney—IgA glomerulonephritis	0.0012	0.0122	CbGeAlD
Nilotinib—CSF1R—lymphoid tissue—IgA glomerulonephritis	0.0012	0.0121	CbGeAlD
Nilotinib—CA1—kidney—IgA glomerulonephritis	0.00116	0.0117	CbGeAlD
Nilotinib—ABL1—kidney—IgA glomerulonephritis	0.0011	0.0112	CbGeAlD
Nilotinib—KIT—lymphoid tissue—IgA glomerulonephritis	0.00109	0.011	CbGeAlD
Nilotinib—ABL1—cortex of kidney—IgA glomerulonephritis	0.00107	0.0109	CbGeAlD
Nilotinib—PDGFRB—lymphoid tissue—IgA glomerulonephritis	0.00106	0.0108	CbGeAlD
Nilotinib—CA4—nephron tubule—IgA glomerulonephritis	0.00103	0.0104	CbGeAlD
Nilotinib—CA1—lymphoid tissue—IgA glomerulonephritis	0.000995	0.0101	CbGeAlD
Nilotinib—ABL1—lymphoid tissue—IgA glomerulonephritis	0.000947	0.0096	CbGeAlD
Nilotinib—CA4—kidney—IgA glomerulonephritis	0.000906	0.00918	CbGeAlD
Nilotinib—CA4—cortex of kidney—IgA glomerulonephritis	0.000882	0.00894	CbGeAlD
Nilotinib—CA2—nephron tubule—IgA glomerulonephritis	0.000854	0.00866	CbGeAlD
Nilotinib—ABCG2—nephron tubule—IgA glomerulonephritis	0.000791	0.00802	CbGeAlD
Nilotinib—CA2—kidney—IgA glomerulonephritis	0.000751	0.00761	CbGeAlD
Nilotinib—CA2—cortex of kidney—IgA glomerulonephritis	0.000731	0.00742	CbGeAlD
Nilotinib—CYP2B6—nephron tubule—IgA glomerulonephritis	0.00073	0.0074	CbGeAlD
Nilotinib—CYP2C8—kidney—IgA glomerulonephritis	0.000715	0.00725	CbGeAlD
Nilotinib—CA2—lymphoid tissue—IgA glomerulonephritis	0.000645	0.00654	CbGeAlD
Nilotinib—CYP2B6—kidney—IgA glomerulonephritis	0.000642	0.00651	CbGeAlD
Nilotinib—CYP2B6—lymphoid tissue—IgA glomerulonephritis	0.000551	0.00559	CbGeAlD
Nilotinib—CYP3A4—kidney—IgA glomerulonephritis	0.000484	0.00491	CbGeAlD
Nilotinib—CYP2D6—kidney—IgA glomerulonephritis	0.000477	0.00483	CbGeAlD
Nilotinib—ABCB1—nephron tubule—IgA glomerulonephritis	0.00039	0.00396	CbGeAlD
Nilotinib—Imatinib—ALB—IgA glomerulonephritis	0.000363	0.131	CrCbGaD
Nilotinib—ABCB1—kidney—IgA glomerulonephritis	0.000343	0.00348	CbGeAlD
Nilotinib—ABCB1—cortex of kidney—IgA glomerulonephritis	0.000334	0.00339	CbGeAlD
Nilotinib—ABCB1—lymphoid tissue—IgA glomerulonephritis	0.000295	0.00299	CbGeAlD
Nilotinib—CYP2C8—Metabolism—PSME3—IgA glomerulonephritis	2.42e-06	7.34e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—IgA glomerulonephritis	2.41e-06	7.33e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—SERPINE1—IgA glomerulonephritis	2.41e-06	7.3e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GNG12—IgA glomerulonephritis	2.39e-06	7.27e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—RRM2—IgA glomerulonephritis	2.39e-06	7.27e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CCNC—IgA glomerulonephritis	2.39e-06	7.26e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GNS—IgA glomerulonephritis	2.39e-06	7.26e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CD80—IgA glomerulonephritis	2.39e-06	7.25e-06	CbGpPWpGaD
Nilotinib—KIT—Disease—PTEN—IgA glomerulonephritis	2.38e-06	7.23e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—AGT—IgA glomerulonephritis	2.38e-06	7.22e-06	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—PIK3CA—IgA glomerulonephritis	2.37e-06	7.21e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GNG12—IgA glomerulonephritis	2.37e-06	7.2e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—RRM2—IgA glomerulonephritis	2.37e-06	7.2e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—C3—IgA glomerulonephritis	2.37e-06	7.2e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD4—IgA glomerulonephritis	2.36e-06	7.16e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NAMPT—IgA glomerulonephritis	2.35e-06	7.14e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—CD4—IgA glomerulonephritis	2.35e-06	7.12e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CCL2—IgA glomerulonephritis	2.35e-06	7.12e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—RHOA—IgA glomerulonephritis	2.34e-06	7.11e-06	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—MMP9—IgA glomerulonephritis	2.33e-06	7.09e-06	CbGpPWpGaD
Nilotinib—BRAF—Disease—NRAS—IgA glomerulonephritis	2.33e-06	7.08e-06	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—MAPK1—IgA glomerulonephritis	2.33e-06	7.06e-06	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—PTEN—IgA glomerulonephritis	2.32e-06	7.04e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—RHOA—IgA glomerulonephritis	2.32e-06	7.04e-06	CbGpPWpGaD
Nilotinib—KIT—Immune System—NRAS—IgA glomerulonephritis	2.3e-06	6.98e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—IQGAP1—IgA glomerulonephritis	2.29e-06	6.96e-06	CbGpPWpGaD
Nilotinib—CA4—Metabolism—PIK3CA—IgA glomerulonephritis	2.28e-06	6.93e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—AGT—IgA glomerulonephritis	2.26e-06	6.85e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—AGT—IgA glomerulonephritis	2.25e-06	6.84e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—PTEN—IgA glomerulonephritis	2.25e-06	6.84e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HPSE—IgA glomerulonephritis	2.25e-06	6.83e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CCL2—IgA glomerulonephritis	2.22e-06	6.74e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—MMP9—IgA glomerulonephritis	2.22e-06	6.74e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NAMPT—IgA glomerulonephritis	2.22e-06	6.73e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—PTEN—IgA glomerulonephritis	2.21e-06	6.7e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—PTEN—IgA glomerulonephritis	2.2e-06	6.67e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NAMPT—IgA glomerulonephritis	2.2e-06	6.67e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—SERPINE1—IgA glomerulonephritis	2.19e-06	6.65e-06	CbGpPWpGaD
Nilotinib—CA2—Metabolism—PIK3CA—IgA glomerulonephritis	2.19e-06	6.65e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—YWHAZ—IgA glomerulonephritis	2.18e-06	6.62e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—NRAS—IgA glomerulonephritis	2.18e-06	6.61e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CD44—IgA glomerulonephritis	2.18e-06	6.61e-06	CbGpPWpGaD
Nilotinib—BRAF—Disease—TGFB1—IgA glomerulonephritis	2.17e-06	6.58e-06	CbGpPWpGaD
Nilotinib—LYN—Immune System—PTEN—IgA glomerulonephritis	2.15e-06	6.54e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CD80—IgA glomerulonephritis	2.15e-06	6.53e-06	CbGpPWpGaD
Nilotinib—ABL1—Immune System—PTEN—IgA glomerulonephritis	2.14e-06	6.5e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—SERPINE1—IgA glomerulonephritis	2.14e-06	6.49e-06	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—PIK3CA—IgA glomerulonephritis	2.14e-06	6.49e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—UCP2—IgA glomerulonephritis	2.13e-06	6.47e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HMMR—IgA glomerulonephritis	2.13e-06	6.47e-06	CbGpPWpGaD
Nilotinib—BRAF—Disease—MAPK1—IgA glomerulonephritis	2.13e-06	6.45e-06	CbGpPWpGaD
Nilotinib—KIT—Disease—NRAS—IgA glomerulonephritis	2.12e-06	6.45e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—HMOX1—IgA glomerulonephritis	2.12e-06	6.42e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—RHOA—IgA glomerulonephritis	2.11e-06	6.41e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—IFNG—IgA glomerulonephritis	2.11e-06	6.41e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PSME3—IgA glomerulonephritis	2.11e-06	6.4e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CD80—IgA glomerulonephritis	2.11e-06	6.39e-06	CbGpPWpGaD
Nilotinib—CA1—Metabolism—PIK3CA—IgA glomerulonephritis	2.1e-06	6.37e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCR5—IgA glomerulonephritis	2.1e-06	6.37e-06	CbGpPWpGaD
Nilotinib—KIT—Immune System—MAPK1—IgA glomerulonephritis	2.1e-06	6.36e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ABCA1—IgA glomerulonephritis	2.09e-06	6.34e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—SERPINE1—IgA glomerulonephritis	2.07e-06	6.29e-06	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—NRAS—IgA glomerulonephritis	2.07e-06	6.28e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ACSL1—IgA glomerulonephritis	2.07e-06	6.27e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—RHOA—IgA glomerulonephritis	2.06e-06	6.26e-06	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—PIK3CA—IgA glomerulonephritis	2.05e-06	6.23e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—C3—IgA glomerulonephritis	2.05e-06	6.23e-06	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—ALB—IgA glomerulonephritis	2.04e-06	6.2e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—PTEN—IgA glomerulonephritis	2.04e-06	6.2e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD4—IgA glomerulonephritis	2.04e-06	6.19e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—PTEN—IgA glomerulonephritis	2.03e-06	6.16e-06	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—PIK3CA—IgA glomerulonephritis	2.02e-06	6.12e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—NRAS—IgA glomerulonephritis	2.01e-06	6.1e-06	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—ALB—IgA glomerulonephritis	2e-06	6.07e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CCL2—IgA glomerulonephritis	2e-06	6.07e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—RHOA—IgA glomerulonephritis	2e-06	6.07e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CD80—IgA glomerulonephritis	2e-06	6.06e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—TYMS—IgA glomerulonephritis	1.99e-06	6.05e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PSME3—IgA glomerulonephritis	1.99e-06	6.03e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—MAPK1—IgA glomerulonephritis	1.99e-06	6.02e-06	CbGpPWpGaD
Nilotinib—KIT—Disease—TGFB1—IgA glomerulonephritis	1.97e-06	5.99e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PSME3—IgA glomerulonephritis	1.97e-06	5.98e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—NRAS—IgA glomerulonephritis	1.97e-06	5.97e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—IgA glomerulonephritis	1.97e-06	5.96e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—NRAS—IgA glomerulonephritis	1.96e-06	5.96e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CCL2—IgA glomerulonephritis	1.96e-06	5.94e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—TBL1XR1—IgA glomerulonephritis	1.95e-06	5.92e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SEC23A—IgA glomerulonephritis	1.95e-06	5.92e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—AGT—IgA glomerulonephritis	1.95e-06	5.92e-06	CbGpPWpGaD
Nilotinib—KIT—Disease—MAPK1—IgA glomerulonephritis	1.94e-06	5.88e-06	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.92e-06	5.84e-06	CbGpPWpGaD
Nilotinib—LYN—Immune System—NRAS—IgA glomerulonephritis	1.92e-06	5.83e-06	CbGpPWpGaD
Nilotinib—ABL1—Immune System—NRAS—IgA glomerulonephritis	1.91e-06	5.8e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ALOX5AP—IgA glomerulonephritis	1.9e-06	5.77e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CD44—IgA glomerulonephritis	1.9e-06	5.76e-06	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.89e-06	5.73e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—CD4—IgA glomerulonephritis	1.88e-06	5.71e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—TGFB1—IgA glomerulonephritis	1.87e-06	5.67e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SERPINE1—IgA glomerulonephritis	1.87e-06	5.67e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—MMP9—IgA glomerulonephritis	1.86e-06	5.65e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CCL2—IgA glomerulonephritis	1.86e-06	5.63e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—PTEN—IgA glomerulonephritis	1.85e-06	5.61e-06	CbGpPWpGaD
Nilotinib—BRAF—Disease—PIK3CA—IgA glomerulonephritis	1.85e-06	5.6e-06	CbGpPWpGaD
Nilotinib—CA9—Metabolism—PIK3CA—IgA glomerulonephritis	1.85e-06	5.6e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—MMP9—IgA glomerulonephritis	1.84e-06	5.59e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—IgA glomerulonephritis	1.84e-06	5.59e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CD36—IgA glomerulonephritis	1.84e-06	5.58e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—MAPK1—IgA glomerulonephritis	1.83e-06	5.56e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—PTEN—IgA glomerulonephritis	1.83e-06	5.56e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.83e-06	5.55e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SERPINE1—IgA glomerulonephritis	1.83e-06	5.55e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—NRAS—IgA glomerulonephritis	1.82e-06	5.53e-06	CbGpPWpGaD
Nilotinib—KIT—Immune System—PIK3CA—IgA glomerulonephritis	1.82e-06	5.52e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ABCA1—IgA glomerulonephritis	1.82e-06	5.52e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—NRAS—IgA glomerulonephritis	1.81e-06	5.5e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—RHOA—IgA glomerulonephritis	1.8e-06	5.47e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.79e-06	5.44e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—HMOX1—IgA glomerulonephritis	1.79e-06	5.44e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—MAPK1—IgA glomerulonephritis	1.79e-06	5.43e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CD44—IgA glomerulonephritis	1.79e-06	5.42e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CD44—IgA glomerulonephritis	1.77e-06	5.38e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—PTEN—IgA glomerulonephritis	1.77e-06	5.36e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—RHOA—IgA glomerulonephritis	1.76e-06	5.35e-06	CbGpPWpGaD
Nilotinib—LYN—Immune System—MAPK1—IgA glomerulonephritis	1.75e-06	5.31e-06	CbGpPWpGaD
Nilotinib—ABL1—Immune System—MAPK1—IgA glomerulonephritis	1.74e-06	5.29e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SERPINE1—IgA glomerulonephritis	1.73e-06	5.26e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—ALB—IgA glomerulonephritis	1.73e-06	5.26e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CD80—IgA glomerulonephritis	1.73e-06	5.24e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—PIK3CA—IgA glomerulonephritis	1.72e-06	5.23e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ABCA1—IgA glomerulonephritis	1.71e-06	5.2e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ABCA1—IgA glomerulonephritis	1.7e-06	5.16e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—TYMS—IgA glomerulonephritis	1.69e-06	5.12e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—TGFB1—IgA glomerulonephritis	1.68e-06	5.11e-06	CbGpPWpGaD
Nilotinib—KIT—Disease—PIK3CA—IgA glomerulonephritis	1.68e-06	5.1e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—MMP9—IgA glomerulonephritis	1.68e-06	5.09e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—RHOA—IgA glomerulonephritis	1.67e-06	5.07e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—PTEN—IgA glomerulonephritis	1.67e-06	5.06e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—MAPK1—IgA glomerulonephritis	1.66e-06	5.04e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—AGT—IgA glomerulonephritis	1.66e-06	5.02e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—MAPK1—IgA glomerulonephritis	1.65e-06	5.01e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—NRAS—IgA glomerulonephritis	1.65e-06	5.01e-06	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—PIK3CA—IgA glomerulonephritis	1.64e-06	4.97e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—NRAS—IgA glomerulonephritis	1.63e-06	4.96e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—PTEN—IgA glomerulonephritis	1.63e-06	4.95e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCL2—IgA glomerulonephritis	1.61e-06	4.87e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—PIK3CA—IgA glomerulonephritis	1.59e-06	4.83e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—MMP9—IgA glomerulonephritis	1.59e-06	4.82e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—PTEN—IgA glomerulonephritis	1.58e-06	4.79e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—NRAS—IgA glomerulonephritis	1.57e-06	4.78e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—RRM2—IgA glomerulonephritis	1.57e-06	4.75e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GNG12—IgA glomerulonephritis	1.57e-06	4.75e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—HMOX1—IgA glomerulonephritis	1.56e-06	4.74e-06	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PTEN—IgA glomerulonephritis	1.56e-06	4.73e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—PIK3CA—IgA glomerulonephritis	1.56e-06	4.72e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CD36—IgA glomerulonephritis	1.56e-06	4.72e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—PIK3CA—IgA glomerulonephritis	1.55e-06	4.71e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.53e-06	4.65e-06	CbGpPWpGaD
Nilotinib—LYN—Immune System—PIK3CA—IgA glomerulonephritis	1.52e-06	4.61e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.52e-06	4.61e-06	CbGpPWpGaD
Nilotinib—ABL1—Immune System—PIK3CA—IgA glomerulonephritis	1.51e-06	4.59e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.5e-06	4.56e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—IgA glomerulonephritis	1.5e-06	4.55e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SERPINE1—IgA glomerulonephritis	1.5e-06	4.55e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.49e-06	4.52e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NRAS—IgA glomerulonephritis	1.49e-06	4.51e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—TYMS—IgA glomerulonephritis	1.47e-06	4.46e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—HMOX1—IgA glomerulonephritis	1.47e-06	4.46e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—HMOX1—IgA glomerulonephritis	1.46e-06	4.42e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—NRAS—IgA glomerulonephritis	1.45e-06	4.41e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NAMPT—IgA glomerulonephritis	1.45e-06	4.4e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—RHOA—IgA glomerulonephritis	1.45e-06	4.39e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—PIK3CA—IgA glomerulonephritis	1.44e-06	4.37e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—MAPK1—IgA glomerulonephritis	1.44e-06	4.35e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—PIK3CA—IgA glomerulonephritis	1.43e-06	4.35e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—MMP9—IgA glomerulonephritis	1.43e-06	4.34e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—PTEN—IgA glomerulonephritis	1.42e-06	4.32e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NRAS—IgA glomerulonephritis	1.41e-06	4.27e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—AGT—IgA glomerulonephritis	1.4e-06	4.25e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MMP9—IgA glomerulonephritis	1.4e-06	4.25e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PTEN—IgA glomerulonephritis	1.39e-06	4.23e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—TYMS—IgA glomerulonephritis	1.39e-06	4.21e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.38e-06	4.2e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—TYMS—IgA glomerulonephritis	1.37e-06	4.17e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CD36—IgA glomerulonephritis	1.36e-06	4.12e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.36e-06	4.11e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—TGFB1—IgA glomerulonephritis	1.35e-06	4.1e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MMP9—IgA glomerulonephritis	1.33e-06	4.03e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—MAPK1—IgA glomerulonephritis	1.33e-06	4.02e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PTEN—IgA glomerulonephritis	1.32e-06	4.01e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PTEN—IgA glomerulonephritis	1.32e-06	4.01e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.31e-06	3.97e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—PIK3CA—IgA glomerulonephritis	1.3e-06	3.96e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—IgA glomerulonephritis	1.3e-06	3.94e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PSME3—IgA glomerulonephritis	1.3e-06	3.94e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—PIK3CA—IgA glomerulonephritis	1.29e-06	3.92e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.28e-06	3.89e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CD36—IgA glomerulonephritis	1.28e-06	3.88e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—ALB—IgA glomerulonephritis	1.27e-06	3.85e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NRAS—IgA glomerulonephritis	1.27e-06	3.85e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CD36—IgA glomerulonephritis	1.27e-06	3.84e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—PIK3CA—IgA glomerulonephritis	1.25e-06	3.78e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NRAS—IgA glomerulonephritis	1.24e-06	3.77e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—AGT—IgA glomerulonephritis	1.22e-06	3.71e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.18e-06	3.58e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NRAS—IgA glomerulonephritis	1.18e-06	3.57e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—PIK3CA—IgA glomerulonephritis	1.18e-06	3.57e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CD44—IgA glomerulonephritis	1.17e-06	3.55e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.16e-06	3.51e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.15e-06	3.5e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—AGT—IgA glomerulonephritis	1.15e-06	3.49e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—PIK3CA—IgA glomerulonephritis	1.15e-06	3.49e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MMP9—IgA glomerulonephritis	1.15e-06	3.48e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PTEN—IgA glomerulonephritis	1.14e-06	3.46e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—AGT—IgA glomerulonephritis	1.14e-06	3.46e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.13e-06	3.44e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ABCA1—IgA glomerulonephritis	1.12e-06	3.4e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—PIK3CA—IgA glomerulonephritis	1.11e-06	3.38e-06	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PIK3CA—IgA glomerulonephritis	1.1e-06	3.34e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.09e-06	3.32e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ALB—IgA glomerulonephritis	1.08e-06	3.26e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.07e-06	3.26e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—IgA glomerulonephritis	1.06e-06	3.21e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NRAS—IgA glomerulonephritis	1.02e-06	3.09e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—PIK3CA—IgA glomerulonephritis	1e-06	3.04e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PIK3CA—IgA glomerulonephritis	9.82e-07	2.98e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PTEN—IgA glomerulonephritis	9.69e-07	2.94e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HMOX1—IgA glomerulonephritis	9.61e-07	2.92e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TGFB1—IgA glomerulonephritis	9.46e-07	2.87e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ALB—IgA glomerulonephritis	9.37e-07	2.84e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PIK3CA—IgA glomerulonephritis	9.33e-07	2.83e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PIK3CA—IgA glomerulonephritis	9.31e-07	2.83e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MAPK1—IgA glomerulonephritis	9.28e-07	2.82e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—TYMS—IgA glomerulonephritis	9.06e-07	2.75e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ALB—IgA glomerulonephritis	8.83e-07	2.68e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ALB—IgA glomerulonephritis	8.75e-07	2.66e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CD36—IgA glomerulonephritis	8.35e-07	2.54e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PTEN—IgA glomerulonephritis	8.21e-07	2.49e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PIK3CA—IgA glomerulonephritis	8.05e-07	2.44e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—AGT—IgA glomerulonephritis	7.52e-07	2.28e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PTEN—IgA glomerulonephritis	7.15e-07	2.17e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PIK3CA—IgA glomerulonephritis	6.84e-07	2.07e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PTEN—IgA glomerulonephritis	6.74e-07	2.04e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PTEN—IgA glomerulonephritis	6.68e-07	2.03e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PIK3CA—IgA glomerulonephritis	5.79e-07	1.76e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ALB—IgA glomerulonephritis	5.77e-07	1.75e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PIK3CA—IgA glomerulonephritis	5.04e-07	1.53e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PIK3CA—IgA glomerulonephritis	4.75e-07	1.44e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PIK3CA—IgA glomerulonephritis	4.71e-07	1.43e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTEN—IgA glomerulonephritis	4.4e-07	1.34e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PIK3CA—IgA glomerulonephritis	3.11e-07	9.43e-07	CbGpPWpGaD
